We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.56%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$672M
AUM Growth
+$54.8M
Cap. Flow
+$50.6M
Cap. Flow %
7.53%
Top 10 Hldgs %
35.69%
Holding
5,893
New
1,202
Increased
1,600
Reduced
1,403
Closed
1,568

Sector Composition

Rank Sector Weight
1 Technology 5.35%
2 Consumer Discretionary 3.08%
3 Materials 2.71%
4 Industrials 2.51%
5 Financials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANY icon
3301
Sphere 3D
ANY
$15.5M
-1
Closed -$19.6K
APYX icon
3302
Apyx Medical
APYX
$163M
$2K ﹤0.01%
1,456
-1,193
-45% -$2.4K
ARES icon
3303
Ares Management
ARES
$30.6B
$2K ﹤0.01%
+104
New +$1.28K
ASA
3304
ASA Gold and Precious Metals
ASA
$1.08B
$2K ﹤0.01%
149
-4
-3% -$35
ASPS icon
3305
Altisource Portfolio Solutions
ASPS
$68M
$2K ﹤0.01%
8
-319
-98% -$67.8K
ATLC icon
3306
Atlanticus Holdings
ATLC
$1.49B
$2K ﹤0.01%
+665
New +$2.06K
ATLO icon
3307
AMES National
ATLO
$270M
$2K ﹤0.01%
68
-2,527
-97% -$60.4K
AUDC icon
3308
AudioCodes
AUDC
$252M
$2K ﹤0.01%
488
-7,857
-94% -$33.7K
BBAR icon
3309
BBVA Argentina
BBAR
$3.51B
$2K ﹤0.01%
+100
New +$2.02K
BBDC icon
3310
Barings BDC
BBDC
$965M
$2K ﹤0.01%
+100
New +$1.83K
BBN icon
3311
BlackRock Taxable Municipal Bond Trust
BBN
$982M
$2K ﹤0.01%
100
-99
-50% -$2.21K
BCE icon
3312
BCE
BCE
$21.1B
$2K ﹤0.01%
49
-512
-91% -$21.4K
BDRX
3313
Biodexa Pharmaceuticals
BDRX
$1.56M
0
BLFS icon
3314
BioLife Solutions
BLFS
$1.65B
$2K ﹤0.01%
+1,039
New +$1.91K
BNDX icon
3315
Vanguard Total International Bond ETF
BNDX
$82.9B
$2K ﹤0.01%
+39
New +$2.1K
BNTC icon
3316
Benitec Biopharma
BNTC
$465M
$2K ﹤0.01%
+5
New +$3.67K
BRW
3317
Saba Capital Income & Opportunities Fund
BRW
$340M
$2K ﹤0.01%
+230
New +$2.21K
BST icon
3318
BlackRock Science and Technology Trust
BST
$1.7B
$2K ﹤0.01%
101
-342
-77% -$5.3K
BUI icon
3319
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$715M
$2K ﹤0.01%
90
-350
-80% -$6.01K
CCBG icon
3320
Capital City Bank Group
CCBG
$882M
$2K ﹤0.01%
121
-1,557
-93% -$22.5K
CCOI icon
3321
Cogent Communications
CCOI
$522M
$2K ﹤0.01%
+63
New +$2.18K
CERS icon
3322
Cerus
CERS
$461M
$2K ﹤0.01%
296
-1,669
-85% -$9.24K
CEV
3323
Eaton Vance California Municipal Income Trust
CEV
$72.8M
$2K ﹤0.01%
110
-790
-88% -$10.9K
CFBK icon
3324
CF Bankshares
CFBK
$236M
$2K ﹤0.01%
211
-664
-76% -$4.72K
CFO icon
3325
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$425M
$2K ﹤0.01%
49

Similar funds

Tower Research Capital (TRC)'s Q1 2016 Portfolio in Review

As of Q1 2016, Tower Research Capital (TRC) held 5,893 positions worth $672M, up 8.9% from $617M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Tower Research Capital (TRC) deployed $50.6M of net new capital in Q1 2016, opening 1,202 new positions and adding to 1,600 existing holdings. Its largest new stake was State Street Industrial Select Sector SPDR ETF: 287,194 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 1.4% a quarter earlier, followed by Consumer Discretionary and Materials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $227M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2016 buy was State Street Industrial Select Sector SPDR ETF: 287,194 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2016, an estimated $52.3M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $227M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P 500 ETF in Q1 2016, selling an estimated $9.03M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 36% of its $672M portfolio in Q1 2016.
  • Tower Research Capital (TRC) opened 1,202 new positions and closed 1,568 in Q1 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 8.9% quarter-over-quarter to $672M.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2016, filed 16 May 2016.